InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Historical Holders from Q2 2021 to Q3 2025

Symbol
NSPR on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
42.1M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22.7M
Holdings value
$54.8M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
40
Number of buys
24
Number of sells
-8
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MARSHALL WACE, LLP 9.99% $67.7M 28.1M MARSHALL WACE, LLP 30 Sep 2025
Rosalind Advisors, Inc. 9.9% +5.56% $25.9M 11M 0% Rosalind Advisors, Inc. 01 Aug 2025
Nantahala Capital Management, LLC 9.99% 0% $10.3M $2.93M 4.26M +40.1% Nantahala Capital Management, LLC 30 Sep 2025
Lawless Michael A 8.6% $8.71M 3.61M Michael A. Lawless 26 Jun 2025
Aberdeen Group plc 5.95% $5.98M 2.48M Aberdeen Group plc 01 Oct 2025
Parkman Healthcare Partners LLC 5.8% $5.88M 2.44M Parkman Healthcare Partners LLC 30 Sep 2025
Nantahala Capital Partners Limited Partnership 5.68% $5.83M 2.42M NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 30 Sep 2025
Velan Capital Investment Management LP 5.1% $5.06M 2.14M Velan Capital Master Fund LP 30 Jul 2025
ORBIMED ADVISORS LLC 4.1% -44.3% $5.14M 2.13M 0% OrbiMed Advisors LLC 30 Sep 2025
Shore Craig 3.5% $3.58M 1.48M Craig Shore 26 Jun 2025

Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 22.7M $54.8M +$20.9M $2.41 40
2025 Q2 14.1M $31.9M +$2.51M $2.27 36
2025 Q1 12.9M $34.7M +$555K $2.69 34
2024 Q4 12.7M $33.4M +$812K $2.63 29
2024 Q3 12.4M $33.2M +$1.21M $2.68 27
2024 Q2 12M $29.9M +$4.43M $2.50 23
2024 Q1 10.2M $24M -$399K $2.37 25
2023 Q4 10.3M $29.1M +$1.72M $2.81 27
2023 Q3 8.76M $28.7M +$2.33M $3.27 25
2023 Q2 8.05M $20.2M +$20M $2.51 22
2023 Q1 88.8K $103K -$54.8K $1.12 12
2022 Q4 156K $137K +$21.6K $0.86 14
2022 Q3 112K $169K -$78.5K $1.50 11
2022 Q2 129K $256K -$10.4K $1.99 10
2022 Q1 140K $456K -$96.9K $3.21 13
2021 Q4 173K $527K -$27.3K $3.02 15
2021 Q3 170K $704K -$1.36M $4.10 12
2021 Q2 451K $2.28M +$2.28M $5.05 14